Sanacorp Pharmahandel AG

euro adhoc: Sanacorp Pharmahandel AG
Justice/Processes
Sanacorp Pharmahandel AG reaches agreement on termination of avoidance action

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Spin-offs 22.10.2007 Sanacorp Pharmahandel AG and the shareholders who brought an action against Sanacorp Pharmahandel AG to set aside the resolutions passed at the Annual General Meeting held on June 27, 2007 (see ad hoc statement of August 21, 2007, 11:36:00 AM) have agreed today to end the dispute by way of a settlement in court. The parties to the settlement - along with the four plaintiffs and Sanacorp Pharmahandel AG, this is also Sanacorp eG Pharmazeutische Großhandlung, which will join the action for the purpose of settlement - have agreed that a one-time special dividend of EUR 0.35 for each preference share be distributed in fiscal year 2008 to all preference shareholders of the defendant. This is to be a compensation for any disadvantages which the plaintiffs allege to suffer from the business combination of the pharmaceutical wholesaling companies Sanacorp Pharmahandel AG and Coopérative d´Exploitation et de Répartition Pharmaceutiques de Rouen S.A., Rouen, France (CERP Rouen). There will be no compensation to the sole ordinary shareholder Sanacorp eG Pharmazeutischen Großhandlung. For this purpose, Sanacorp eG Pharmazeutische Großhandlung undertakes towards the plaintiffs and all other preference shareholders of Sanacorp Pharmahandel AG to agree on a change of the Articles of Incorporation on the occasion of the next annual general meeting of Sanacorp Pharmahandel AG, enabling the above-stated special dividend. If the statutory requirements are met, i.e. if there is sufficient net retained profit in particular, the special dividend will be approved in the Annual General Meeting of Sanacorp Pharmahandel AG in 2009 and paid out then. In addition, Sanacorp Pharmahandel AG has accepted the duty to keep the plaintiffs and the other preference shareholders informed. The plaintiffs, in turn, will withdraw the action brought against Sanacorp Pharmahandel AG to set aside the resolutions passed at the Annual General Meeting held on June 27, 2007 in relation to the items 5, 7 and 8 of the agenda. Sanacorp Pharmahandel AG will bear the cost of the litigation and the settlement. To become effective, the settlement requires a declaration by the court. Details of the settlement, if it is reached upon the advice and request of the responsible court and if matching pleadings of all parties involved are filed, will be published in the newspapers authorized to publish company announcements. Planegg, October 22, 2007 Sanacorp Pharmahandel Aktiengesellschaft The Management Board end of announcement euro adhoc 22.10.2007 17:15:00 -------------------------------------------------------------------------------- ots Originaltext: Sanacorp Pharmahandel AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Dr Thomas Strieder Telefon: +49(089) 8581 494 E-Mail: ir@sanacorp.de Branche: Wholesale ISIN: DE0007163131 WKN: 716313 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / official dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse München / official dealing

Das könnte Sie auch interessieren: